SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 11:15 a.m. Eastern Time.
A live audio webcast and replay of the presentation may be accessed for 30 days through the “Recent Events” section of Minerva’s website at http://ir.minervasurgical.com.
ABOUT MINERVA SURGICAL – THE UTERINE HEALTH COMPANY
Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.
MEDIA CONTACT
Mike Clapper
[email protected]
804-295-7676
INVESTOR RELATIONS CONTACT
Caroline Corner
[email protected]
415-202-5678
RELATED LINKS
https://www.aubandme.com
https://www.minervasurgical.com
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.